small
Lv3
240 积分
2023-05-06 加入
-
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
4个月前
已完结
-
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
4个月前
已完结
-
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study
5个月前
已完结
-
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
5个月前
已完结
-
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project
5个月前
已关闭
-
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
5个月前
已完结
-
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
5个月前
已完结
-
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
5个月前
已关闭
-
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
5个月前
已完结
-
Venetoclax and Hypomethylating Agent in Previously Untreated Higher‐Risk Myelodysplastic Syndromes and Genotype Signatures for Response and Prognosis: A Real‐World Study
5个月前
已关闭